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Adaptation Cost and Tractability in Robust ART
Purpose: In this paper, a framework for online robust adaptive radiation ther-
apy (ART) is discussed and evaluated. The purpose of the presented approach to
ART is to: (i) handle interfractional geometric variations following a probability dis-
tribution different from the a priori hypothesis, (ii) address adaptation cost and (iii)
address computational tractability.
Methods: A novel framework for online robust ART using the concept of Bayesian
inference and scenario-reduction is introduced and evaluated in a series of treat-
ment on a one-dimensional phantom geometry. The initial robust plan is generated
from a robust optimization problem based on either expected-value- or worst-case-
optimization approach using the a priori hypothesis of the probability distribution
governing the interfractional geometric variations. Throughout the course of every
treatment, the simulated interfractional variations are evaluated in terms of their
likelihood with respect to the a priori hypothesis of their distribution and violation
of user-specified tolerance limits by the accumulated dose. If an adaptation is con-
sidered, the a posteriori distribution is computed from the actual variations using
Bayesian inference. Then, the adapted plan is optimized to better suit the actual
interfractional variations of the individual case. This adapted plan is used until the
next adaptation is triggered. To address adaptation cost, the proposed framework
provides an option for increased adaptation frequency. Computational tractability
in robust planning and ART is addressed by approximation algorithms to reduce the
size of the optimization problem.
Results: According to the simulations, the proposed framework may improve
target coverage compared to the corresponding non-adaptive robust approach. In
particular, combining the worst-case-optimization approach with Bayesian inference
may perform best in terms of improving CTV coverage and organ-at-risk (OAR) pro-
tection. Concerning adaptation cost, the results indicate that mathematical methods
like Bayesian inference may have a greater impact on improving individual treatment
quality than increased adaptation frequency. In addition, the simulations suggest that
the concept of scenario-reduction may be useful to address computational tractability
in ART and robust planning in general.
Conclusion: The simulations indicate that the adapted plans may improve tar-
get coverage and OAR protection at manageable adaptation and computational cost
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within the novel framework. In particular, adaptive strategies using Bayesian in-
ference appear to perform best among all strategies. This proof-of-concept study
provides insights into the mathematical aspects of robustness, tractability and ART,
which are a useful guide for further development of frameworks for online robust
ART.
Keywords: adaptive radiation therapy, interfractional variations, robust
optimization, stochastic programming, scenario reduction, bayesian infer-
ence
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I. INTRODUCTION
In adaptive radiation therapy (ART), the treatment plan is adapted in order to account
for interfractional geometric variations in the individual patient. These changes and their
impact on the accumulated dose can be monitored in the course of image-guided radiation
therapy (IGRT). Traditionally, interfractional geometric variations are handled by adding
safety margins around the organs-at-risk (OARs) and clinical target volume (CTV). The
CTV is expanded to a larger planning target volume (PTV) by using population based
margin-recipes such as presented by Stroom et al.30 and van Herk et al.36,37. This PTV is
then irradiated with the prescribed curative dose. However, the PTV-concept has limitations
which lead to research on robust treatment planning using the concepts of stochastic- and
minimax-optimization33. These methods directly take into account the presence of interfrac-
tional variations into the optimization process. In particular, treatment modalities which
are sensitive to interfractional variations, such as intensity modulated radiotherapy (IMRT)
and intensity modulated proton therapy (IMPT) seem to benefit from robust planning33.
Typically, these variations are modeled as discrete scenarios with corresponding probabilities
according to an a priori estimate of their distribution33. The resulting treatment quality
relies on the a priori hypothesis on distribution and the order of magnitude of the interfrac-
tional variations.
However, in the event of interfractional variations that are distributed differently than
anticipated in the a priori hypothesis, applying the same plan throughout the course of treat-
ment may impair treatment quality40. Thus, ART may improve treatment quality6,18,22. In
general, the planning process is time intensive and requires a cross-disciplinary team of radia-
tion oncologists, dosimetrists, therapists and medical physicists. If a plan has to be adapted,
the contours of the tumor(s) and OARs may be adjusted, the plan reoptimized, approved by
the radiation oncologist and reexamined for patient-specific quality assurance (QA)22. Typ-
ically, ART is categorized into online and offline ART. In online ART, the plan is adapted
with the patient lying in treatment position, which limits the time available for replanning
and reexamining the adapted plan. In offline ART, the plan is adapted and examined in be-
tween fractions. In general, ART is considered expensive in terms of time and resources such
as workforce and computation time. Therefore, ART is not commonly used in conventional
clinical routine. Despite obstacles in workflow implementation, ART has been the subject of
4
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various theoretical and practical studies on clinical patient data. Theoretical studies focus
on the problem formulation and optimization approach. According to our previous stud-
ies5,6, the concept of combining robust optimization approaches with adaptive replanning
can handle interfractional geometric variations. In particular, this combination can outper-
form the conventional non-adaptive treatment approach in terms of CTV coverage and OAR
protection. Moreover, the connection between more or less conservative approaches to ro-
bust planning and optimization variables which are either time-and/or-scenario dependent or
static is investigated. On the contrary, the majority of theoretical studies use radiobiological
models to adapt and personalize the treatment schedule and fraction size2,19,20,28. However,
radiobiological models are considered uncertain and therefore hardly used in clinical prac-
tice1,4. Practical studies are carried out on a sample of in-house treated patients in order to
study the potential of ART through reoptimization22,29 or a plan-of-the-day approach17,22,
and how to manage the increasing workload. These studies emphasize the importance of
identifying those patients who may benefit the most from ART and determining the appro-
priate adaptation frequency. Moreover, the deficiencies of the current conventional approach
to planning, time limitations and computational tractability are discussed. However, these
studies do not take a systematic approach to ART planning.
In our previous work5,6, robust optimization approaches were combined with adaptive re-
optimization to establish mathematical models of frameworks for robust ART. These models
were evaluated in simulation and mathematical studies in the context of offline robust ART.
In this work, the findings of the previous studies are used to extend our research in mathe-
matical modeling to design a framework for online robust ART. Here, a framework for online
robust ART is presented and evaluated on a one-dimensional phantom geometry for a series
of simulated treatments. The aim of this proof-of-concept study is to identify the relevant
mathematical properties of such a framework which is supposed to handle the following
issues. First, inaccuracies in the a priori estimate of the probability distribution of the in-
terfractional geometric variations are handled by employing Bayesian inference to compute
the a posteriori distribution of the actually occuring variations for each individual case. Sec-
ond, the issue of computational tractability is addressed by using approximation algorithms
to reduce the size of the robust optimization problem. Third, the issues of adaptation costs
and the appropriate adaptation frequency are addressed by the presented adaptive strate-
gies and mathematical adaptation triggers. By evaluating the proposed framework on a
5
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one-dimensional phantom geometry, features in the resulting dose distributions can be asso-
ciated with the corresponding optimization parameter. This allows us to gain insights into
the relevant mathematical properties for an effective framework for robust ART5,6,10,14,23.
Such insights will be valuable for further development of this framework.
II. METHODS
In this section, we present the mathematical foundation of the proposed framework for
online robust ART. First, the novel concept is presented and motivated. Second, the concept
of Bayesian inference is introduced and its use in the proposed framework is described.
Third, the use of an algorithm for scenario-reduction and tree-generation from the literature
to address the issue of computational tractability is motivated. Fourth, the three adaptive
strategies. Fifth, the two robust optimization approaches employed in the framework are
discussed.
II.A. The Proposed Framework for Online Robust ART
In this online framework, see Figure 1(b), treatment starts with an initial robust plan.
This initial robust plan is the optimal solution of the robust optimization problem which
accounts for interfractional variations according to a population-based a priori hypothesis
of their distribution. During treatment, the actual interfractional variations are evaluated
in terms of their likelihood with respect to the a priori hypothesis of their distribution
and their impact on the accumulated dose with respect to user-specified criteria. Thus,
both mathematical and clinical criteria may trigger adaptive replanning. It is assumed that
the actually occuring interfractional variations and their impact on the accumulated dose is
measured before plan delivery as part of the daily IGRT-routine. Here, systematic errors are
assumed to be corrected during the IGRT-routine. If an adaptation is triggered, parameters
in the robust optimization problem are updated in response to the measured interfractional
variations using Bayesian inference. This modified robust optimization problem is then
solved in order to generate the adapted plan. Typically, any plan has to be approved by
an oncologist before delivery. Here, this process is handled by evaluating the improvement
of objective function value. Then, the adapted plan is delivered in the current and the
6
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(a)Schematic planning process and represenation
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(b)Representation of our robust adaptive
framework in an online setting.
Fig. 1 Comparison between the non-adaptive robust treatment strategy and our proposed robust
adaptive framework to support the decision-making process. The white boxes represent actions
which are performed in the treatment planning system, while the grey boxes represent actions
performed while the patient is lying on the treatment couch.
subsequent fractions until the next adaptation will be triggered.
II.B. Bayesian inference
In this framework, the concept of Bayesian inference is applied in the following manner.
The interfractional geometric variations are modeled to be independent and identically dis-
tributed (i.i.d.) according to a normal distribution N (0, σ2prior), where the mean is assumed
to be zero. The standard deviation represents the amplitude of the interfractional variations
and is considered to be case-specific. Due to the lack of case-specific data, a population-
based estimate σprior is used. During the course of treatment case-specific data become
available, denoted by ξ¯, through the daily monitoring of the interfractional variations. If
the plan is adapted at tP , the following measurements ξ¯ = {ξ1, . . . , ξtP } of the individual
case are available. In case an adaptation has taken place at a previous time instant tpP , the
sample will be denoted by ξ¯ = {ξtpP , . . . , ξtP }. Given our measurements ξ¯, the a posteriori
7
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distribution pi(σ2|ξ¯) of the case-specific variance σ2 is computed from
pi(σ2|ξ¯) = pi(ξ¯|σ
2)pi(σ2)
pi(ξ¯)
. (1)
The a posteriori distribution pi(σ2|ξ¯) is a conditional distribution of the variance given the
data ξ¯, where pi(ξ¯|σ2) denotes the likelihood of the measurements given the a priori distri-
bution pi(σ2). Moreover, pi(ξ¯) denotes the marginal distribution which gives the probability
that the data ξ¯ are measured. Here, the a posteriori distribution is used to compute the
point estimate E[σ2|ξ¯] of the case-specific variance. We follow Casella and Berger9 (Ch.
7,p. 359) by choosing the inverted gamma distribution IG(α, β) as the a priori distribution
of σ2. Taking into account our measurements with sample size k = |ξ¯|, we get the following
posterior distribution of σ2, IG
(
α + k−1
2
,
(
S2k(k−1)
2
+ 1
β
)−1)
where Sk denotes the unbiased
variance S2k =
1
k−1
∑k
i=1(ξi − µ)2, and α = 1 and β = 1. Then, the point estimate E[σ2|ξ¯] of
the case-specific variance is given by
σ2post = E[σ2|ξ¯] =
S2k +
2
β(k−1)
1 + 2(α−1)
k−1
, (2)
which is used during adaptive reoptimization in the proposed framework.
II.C. Tractability and Scenario Reduction
In robust planning, interfractional variations are typically modeled as discrete scenarios33.
The number of all possible scenario realizations grows exponentially with the number of
fractions. As a consequence, optimization problems including all scenarios may become
expensive to solve or even intractable. In this framework, the issue of tractability is addressed
by applying the concept of scenario-reduction and scenario-tree generation to robust ART.
In general, scenario reduction algorithms approximate the large original problem by a subset
of scenarios of a predefined cardinality or accuracy12,16,38. Such methods are commonly used
in decision making models in portfolio and risk managment for electrical power utilities that
deal with uncertainty12,16. To the best of our knowledge, this is the first application of such
methods to robust planning and ART. Here, we choose to apply the scenario-reduction-
and tree-generation algorithm proposed by Gro¨we-Kuska et al.16, which is well-suited to
handle the issue of intractability in this paper. The concept of the algorithm used in this
framework is presented in pseudo-code in Algorithm 1 and 2 and described as follows. This
8
Adaptation Cost and Tractability in Robust ART
algorithm stepwise reduces the number of nodes in a fan of individual scenarios, as similar
scenarios are bundled together and the tree structure is modified. To determine whether a
scenario is discarded or preserved, the Kantorovich distance24 (p. 427-430) is used to trade
off scenario probabilities and distances of scenario values. In this framework, the decision
maker may specify the number of preserved scenarios at fraction T . The scenarios to be
discarded are identified by recursively applying a maximum reduction strategy (MRS)16
(eq.(2)) from T, T − 1, . . . , 1. Given the accuracy  with which the probability distribution
of the reduced set approximates the probability distribution of the original set, the index
set J of maximal cardinality is determined by∑
i∈J
pi min
j /∈J
cT
(
ωi, ωj
) ≤ . (3)
The distance between scenarios, ωi and ωj, over the total time horizon is denoted by
cT (ω
i, ωj) :=
∑T
τ=1 |ωiτ − ωjτ |. Thus, J contains the indices of the discarded scenarios. The
preserved scenarios ωj, j /∈ J are assigned new probabilities qj, qj ≥ 0,
∑
j qj = 1, according
to the optimal redistribution rule16
qi := pj +
∑
i∈J(j)
pi,where J(j) := {i ∈ J : j = j(i)}, j(i) ∈ arg min
j /∈J
cT
(
ωi, ωj
)
, ∀ ∈ J. (4)
According to the rule given by (4), the new probability of a preserved scenario sequence is
equal to the sum of its former probability pj and of all probabilities of the deleted scenar-
ios,
∑
i∈J(j) pi, that are closest to it with respect to cT (ω
i, ωj).
II.D. Adaptive Strategies
The adaptive strategies in this proposed framework are designed to address the issues of
adaptation costs and appropriate adaptation frequency. To evaluate the interfractional vari-
ations and their impact on the accumulated dose in a straightforward manner, mathematical
and user-specified adaptation triggers are introduced. For the purpose of performing simu-
lations in this study, dose-volume-points are chosen as user-specified adaptation triggers.
The user-specified criteria used in the simulatios follow recommendations for a prostate
case in the ICRU83 report26. In terms of OAR protection, 25% of the bladder and 35% of the
rectal wall should not receive more than 32% and 45% of the prescribed dose, respectively.
Here, the D25 and D35 criteria are used for the right and left OAR, respectively. Concerning
9
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the mathematical adaptation triggers, the actual interfractional variations are evaluated in
terms of their likelihood with respect to the current estimate of their probability distribution.
If more than half of the actual variations have a likelihood of less than 60%, adaptation will be
triggered followed by computing the a posteriori estimate of case-specific standard deviation
with Bayesian inference. Here, the threshold of 60% is chosen to account for deviations
larger than one standard deviation for the majority of the simulated treatments. However,
this threshold can be chosen by the decision-maker. Then, the potential improvement of the
adapted plan is assessed by comparing the objective function value evaluated at the adapted
and previous plan for approval. For this purpose, the objective function is parameterized
with the current estimate of case-specific standard deviation. In this framework, three
adaptive strategies are introduced and evaluated which are referred to as strategy A, B and
C. All three strategies share the approach to take into account the already delivered dose
and remaining number of fraction.
• In strategy A, the adapted plan is optimized with respect to the remaining dose to be
delivered and the remaining numbers of fractions. Treatment plan adaptation can be
10
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performed whenever adaptation has been triggered.
• In strategy B, Bayesian inference is used to compute the case-specific standard devi-
ation. Then the adapted plan is optimized with respect to the case-specific standard
deviation, remaining dose and time-horizon. However, the plan is adapted only if a
sufficient amount of data ξ¯ is available, leading to a delay in between adaptations.
Here, the delay is set to five fractions corresponding to one week of a six week long
treatment. It is the goal to evaluate potential improvements by adapting plans using
Bayesian inference. For that purpose, strategy A is a lower benchmark.
• In strategy C, Bayesian inference is used to compute the case-specific standard de-
viation. In contrast to strategy B, an adapted plan can be optimized whenever an
adaptation is triggered. In other words, if the previous adaptation lies less than five
fractions behind, the plan is adapted with respect to the current estimate of the case-
specific standard deviation like in strategy A. Otherwise, if the previous adaptation
lies more than five fractions behind, the case-specific standard deviation is updated by
using Bayesian inference followed by optimizing the adapted plan like in strategy B. It
is the goal to evaluate the extent of potential improvements by combining the option
for frequent adaptations with Bayesian inference.
In order to evaluate the potential improvements of the proposed framework for robust ART,
the non-adaptive robust approach is used as a lower benchmark to evaluate the resulting
dose distribution at the end of the treatment. By combining mathematical, user-specified
and the three adaptive strategies, the issues of adaptation costs and adaptation frequency
may be handled in a systematic and less biased fashion.
II.E. Robust Planning Models
Here, robust optimization approaches are used to optimize the initial and adapted ro-
bust plans. In our previous studies, expected-value-, worst-case-and conditional-value-at-
risk (CVaR) optimization was used to evaluate robust approaches with varying grades of
conservativeness. The results with the clearest trends in the previous studies were given
by expected-value- and worst-case-optimization. Therefore, the expected-value- and worst-
case-optimization approach are used in this framework. While expected-value-optimization
11
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is considered the least conservative, worst-case-optimization is the most conservative ap-
proach. In general, the proposed framework can be combined with any other robust opti-
mization approach. The robust plans u are optimized to handle interfractional variations
such that the delivered final dose xT resembles the prescribed dose distribution dT as well
as possible. This goal is expressed through the function g(xT , dT ) chosen by the decision-
maker. The details to the particular function g(xT , dT ) used in this proof-of-concept study
is discussed later. Here, the expected-value-optimization approach is given by
min
u≥0
Eσ
[
g(xT (u, ω¯
T
1 ), dT )
]
, (5)
while the worst-case-optimization approach is formulated to
min
u≥0
max
ω¯T1 ∈{Ωσ×···×Ωσ}T
g(xT (u, ω¯
T
1 ), dT ), (6)
where the subscript σ represents the parametrization of the objective function with respect
to the current estimate of the case-specific standard deviation; and ω¯T1 denotes the possible
scenario realizations from fraction one to T. All possible scenario realizations are summarized
in the set {Ωσ×· · ·×Ωσ}T of the cardinality |Ω|T . The set Ω contains the scenarios ω which
may occur at every fraction.
III. COMPUTATIONAL STUDY
III.A. Optimization Formulation and Phantom Geometry
In this proof-of-concept study, the dose criterion chosen as the objective function g(xT , dT )
penalizes the deviation from a uniform dose of one in the CTV and a dose of zero elsewhere
according to∑
r∈R
wr
∑
n∈Nr
vn,r(x(u, ω¯
T
1 )T,n − dT,n)2, (7)
where n denotes the voxel index contained in the index set Nr for every region of inter-
est (ROI) r ∈ R, denoting the set of all ROIs. The conventionally used important weights
and the relative volumes are denoted by wr and vn,r, respectively. The relative volumes
in every ROI satisfy
∑
n∈Nr vn,r = 1. To emphasize the mathematical properties of this
framework, a convex objective function as given by (7) is chosen to exploit its smoothness,
12
Adaptation Cost and Tractability in Robust ART
convexity and the resulting globally optimal solutions of (5) and (6). Thus, the resulting
initial and adapted robust plans can be interpreted in a straightforward manner. In general,
any type of objective function can be combined with the proposed framework. However, the
characteristics such as convexity are useful to study novel frameworks from a mathematical
perspective, as done by Unkelbach and Oelfke35 and Fredriksson13 among others6,7,15,34. In
addition, the expected value of the quadratic penalty (5) has advantageous in terms of com-
putational tractability. The objective function E
[∑
r∈Rwr
∑
n∈Nr vn,r(x(u, ω¯
T
1 )T,n − dT,n)2
]
can be reformulated by exploiting its structure and the assumption of i.i.d. interfractional
variations, which gives∑
r∈R
wr
∑
n∈Nr
vn,r
[
1
T
Var[x(u, ω)n] + (TE[x(u, ω)n]− dT,n)2
]
. (8)
Then, the optimal plan is computed from (8) independent of the number of fractions, as
demonstrated in our previous work5. However, worst case optimization problems such as (6)
are intractable due to an exponential growth in scenarios13. Instead, a heuristic is used to
find an approximative solution. In our framework, we apply the scenario reduction and tree
generation algorithm, presented in section II.C, to create a tractable problem from which an
approximate solution can be obtained. To allow for spatial and temporal variations in the
plans, constraints are used in the optimization problem, such that the daily fraction may
vary in the interval of (1− γ)dT
T
≤ But ≤ (1 + γ)dTT , where γ ≥ 0 specifies the user-defined
lower and upper bound on the daily dose.
As in our previous study5 the proposed framework is evaluated on a one-dimensional
phantom geometry, see Figure 2. This idealized geometry contains one CTV, located between
-1.2 and 1.2 cm, and two OARs which are in the intervals of [−2,−2.2] cm and [2, 3] cm. The
OARs are placed asymmetrically around the CTV. The geometry in question schematically
represents both a slice of a two-dimensional phantom and an intersection of a sagittal and
transversal cut of a three-dimensional patient-geometry. Here, the geometry is discretized
into N = 60 voxels. The interfractional variations are modeled as translational whole-
body shifts which can be interpreted as movements in the anterior or posterior direction.
These shifts are included in the optimization process as i.i.d. discrete scenarios which are
summarized in the set Ω = {ω1, ω2, . . . , ωU}, where U denotes the cardinality of Ω. These
scenarios are derived from a discretized normal distribution N (0, σ2prior). In this study, σprior
is set to 0.5 cm which agrees with the range of movements in the anterior-posterior direction
13
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-3 3-2.2 2-1.2 1.2
left OAR CTV right OAR
Fig. 2 One-dimensional patient phantom. The dimensions are given in cm.
reported in the literature for the prostate3,21,39, cervix CTV31,32 and head and neck tumors8.
In this framework, the accumulated dose xt at fraction t is computed according to
xt = xt−1 +BS(ωt)u for t = 1, . . . , T. (9)
The translational shifts are modeled by the socalled shift-operator matrix S(ωt) which cor-
responds to a translational shift of the plan. Since rigid translations are considered only, the
shift of a plan is equivalent to a translational shift of the patient in the opposite direction.
Dose deposition in the geometry is modeled by the dose-deposition matrix B. Before the
start of the treatment the patient is not supposed to receive dose and therefore, x0 is set
to zero. By subjecting this idealized geometry model to rigid translations with respect to
the isocenter, dose computation, tracking of the accumulated dose and reoptimization of
the adapted plan can be performed in a straightforward manner and computational effort is
reduced. As a consequence, features in the accumulated dose can be directly associated with
parameters in the proposed mathematical model. This idealized setting has been useful for
focusing on the mathematical perspective of optimization for ART in our previous papers5,6.
In the literature, examples of the use of one-dimensional phantom geometries to evaluate the
mathematical properties of a novel approach are given by Chan et al.10 among others14,23.
III.B. Dose Calculation, Notation and Numerical Optimization
Here, the radiation plans are delivered by a perpendicular oriented field and the absorbed
dose in each voxel is modeled by Gaussian point-spread functions at a spacing of 1 mm with
a standard deviation of 3 mm, which are represented by the matrix B in (9). To reduce
computational effort, the number and positions of bixels M are considered identical with
those of the voxels N . Thus, the dimensions of the accumulated dose, radiation plans, shift-
matrix and dose dose-deposition matrix can be simplified to xt ∈ RN , u ∈ RN , S(ω) ∈ RN×N
and B ∈ RN×N , respectively. The experimental study is performed using MATLAB 9.4 and
14
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the IBM optimization solver CPLEX in the studio version 12.8. The optimization weights
in (7) for the CTV, both OARs and external are set to 100, 10 and 1, respectively.
III.C. Sensitivity Analysis, Scenario Reduction and Framework Evaluation
First, a sensitivity analysis is conducted with the goal to evaluate changes in the objective
function value of (5) and (6) as a function of the standard deviation. Here, the objective
function value is a measure of treatment quality. In other words, this analysis is conducted
to evaluate how treatment quality is affected, if the distribution of the actual interfractional
variations differ from the a priori hypothesis. For this purpose, the unconstrained robust
optimization problems (5) and (6) are parameterized with respect to standard deviations in
the interval of [0.0001, 1]. Then, an optimal solution u∗(σ) is computed for every value in the
interval to obtain the corresponding objective function values fσ(u
∗(σ)). These objective
function values fσ(u
∗(σ)) represent the ground truth. The deviation from the ground truth
is evaluated for plans generated for four a priori estimates σprior = {0.1, 0.3, 0.5, 0.7}.
Second, the suitability of the scenario-reduction and tree-generation algorithm for the
proposed framework is investigated. To address computational tractability, the algorithm is
combined with worst-case-optimization. The original scenario tree contains 100.000 scenar-
ios randomly generated from the a priori hypothesis N (0, σ2prior). The scenario-reduction
algorithm is applied to reduce the original tree to smaller trees with the following number
of scenarios ST = {10.000, 5000, 1000, 500, 100}. In this evaluation, the plans obtained from
the original tree is compared to the plans obtained from the reduced trees.
Third, the proposed framework is evaluated in its ability to handle inaccurately estimated
interfractional variations. For this purpose, 200 simulated treatments, each consisting of 30
fractions, are performed on the one-dimensional geometry. The population of simulated
treatment is generated by discretizing the normal distribution with a standard deviation
modeled as a random variable. The standard deviation for each treatment is taken from
the uniform distribution U[0.2, 0.7] cm. Such a wide range of values has been documented
for interfractional variations in the literature3,8,21,31,32,39. A cut-off is applied such that 95%
most probable scenarios in the joint distribution are included and the distribution is renor-
malized. To ensure a fair evaluation of the proposed framework with a variety of robust
adaptive strategies and comparison with the corresponding non-adaptive robust strategies,
15
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(a)Optimal plans u∗(σ) generated by
solving the unconstrained problem (5)
for a variety of σ.
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(b)Optimal plans u∗(σ) generated by
solving the unconstrained problem (6)
for a variety of σ.
Fig. 3 Illustration of the sensitivity of the robust plans u∗(σ) for various σprior = {0.1, 0.3, 0.5, 0.7}.
this population of 200 treatments is used.
The statistical accuracy of the computational study is evaluated by using the bootstrap
resampling method. Bootstrap resampling is a statistical method which is used in studies
conducted on a limited number of patient cases11,27. This method builds on the basic idea
to randomly draw samples with replacement from an original dataset. These drawn samples
are supposed to be of the same size as the original dataset. By repeating this process k
times, k bootstrap data sets will be generated. In this study, the bootstrapping is applied to
investigate the spread of mean and absolute value of the largest variations in the original data
set. This resampling procedure is carried out 1000 times to generate 1000 bootstrap data
sets. From these datasets, the probability density estimate is computed for the mean and
standard deviation of each dataset. This evaluation show a narrow spread in the distribution
of our bootstrap sample mean and standard deviation, which indicates that the population of
200 treatments is representative to draw valid conclusions from this analysis of the proposed
framework.
16
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IV. RESULTS
IV.A. Sensitivity Analysis
In the sensitivity analysis, changes in the objective function value fσ(u
∗(σ)) for the
expected-value- and worst-case-optimization approach as a function of the standard de-
viation are evaluated. In addition, it is investigated how the objective function values may
change as a result of interfractional variations following a distribution different from the a
priori hypothesis. The results of this analysis are illustrated in Figures 4.3(a) and 4.3(b) for
expected-value- and worst-case-optimization, respectively. The objective function values for
the worst-case-optimization approach do not appear to increase continuously with σ. This
appearance of noise is caused by the use of heuristics to obtain the optimal solutions u∗(σ)
from the worst-case-optimization approach. This is in contrast to the values for the expected-
value-optimization approach in which the optimal solutions are computed in an exact manner
by exploiting its structure. In both optimization approaches, the objective function values
for the ground truth, represented by the red dotted line, increase with the standard devia-
tion. This observation may indicate that the resulting treatment quality may decline as the
amplitude of the variations increases. The results suggest that, the objective function value
for the expected-value-optimization approach grows at a ’slower’ rate as the standard devi-
ation increases, while the objective function value for the worst-case-optimization approach
grow at a ’faster’ rate. Concerning the sensitivity of solutions to deviations from the a
priori hypothesis, the following trends are observed. If the distribution of the variations has
been underestimated, i.e. σprior < σ, the optimal solutions obtained from expected-value-
optimization seem to result in rather small changes except for σprior = 0.1 cm, i.e. strong
underestimation, where the objective function value increases the most. Apart from the
sensitivity of solutions u∗(σprior = 0.1) to large deviations, the increase in objective function
value may be explained by higher importance weights for the CTV. Solutions obtained from
the worst-case-optimization approach lead to very large deviations from the ground truth. If
the distribution of the variations has been overestimated, i.e. σprior > σ,, to a small extent,
solutions from the expected-value-optimization approach result in very small deviations from
the ground truth. However, the smaller the standard deviation of the actual variations, the
larger the deviation in objective function value. These deviations are not as large as in the
17
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Fig. 4 Comparison of plan optimized with the original tree with the plans optimized for reduced
trees according to ST = {10.000, 5000, 1000, 500}.
case of underestimation, since the importance weights for the OARs are lower than those for
the CTV. On the other hand, solutions obtained from the worst-case-optimization approach
do not appear to deviate to a great extent from the ground truth. An exception is given
by the solution for σprior = 0.7cm, which represents the largest extent of overestimation in
this study. Overall, solutions of the worst-case-optimization approach appear to be more
sensitive to underestimation of the distribution of interfractional variation by the a priori
hypothesis.
IV.B. Application of the Scenario-Reduction- and Tree-Generation Algorithm
to Robust ART
Here, the suitability of the concept of scenario-reduction for robust planning and ART is
investigated. According to the plan profiles shown in Figure IV.B, the plan of the original
tree appears to be approximated best by the plan obtained from the reduced tree with 10.000
scenarios. Thus, this value is used in the proposed robust adaptive framework. However,
this analysis has been carried out in an idealized setting and therefore a reduced scenario
tree may be of different size for a two- or three-dimensional geometry.
IV.C. Framework for Robust Adaptive Radiation Therapy
In this study, the performance of the proposed framework to handle uncertainty in sim-
ulated treatments is evaluated in comparison with the corresponding non-adaptive robust
18
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approach. The performance is measured by the ability of the framework to provide sufficient
CTV coverage and protect the OARs with high probability. CTV coverage is evaluated
by using dose-probability-histograms, as shown in Figure 4.5(a) and 4.5(b). These dose-
probability-histograms illustrate the probability that the final accumulated dose xT satisfies
the ICRU-guideline25 that 99% of the CTV will receive at least 95% of the prescription
dose. The probability that 99% of the CTV will receive at least a certain dose or above is
plotted along the y-axis, while the x-axis illustrates dose levels from 60% to 100% of the
prescription dose. As a visual guide, the ICRU guideline is visualized by the vertical line in
Figures 4.5(a) and 4.5(b). The evaluation of OAR dose exposure focuses on the right OAR,
since it is closer to the CTV and therefore at greater risk of high dose exposure than the
left OAR. Dose exposure to the right OAR is evaluated by illustrating the 90th percentile of
the final dose accumulated over simulated treatments in Figures 4.6(a) and 4.6(b). The 90th
percentile gives the upper threshold of dose level for 90% of the evaluated treatments. Thus,
the overall dose exposure in the OARs for the majority of the simulated treatments can
be assessed. In addition, the suitability of the expected-value- and worst-case-optimization
approach is evaluated by using Figures IV.C and IV.C. Moreover, these visualized results
show trends in the accumulated doses as result of employing the robust adaptive strate-
gies A, B and C. Thus, the impact of using Bayesian inference, varied adaptation frequency
and adaptation triggers can be studied.
The results in Figures 4.5(a) and 4.5(b) suggest that the robust adaptive framework
may improve target coverage in comparison with the corresponding non-adaptive robust
approach. However, a superior adaptive adaptive strategy cannot be identified from these
results. Concerning OAR sparing, the results in Figures 4.6(a) and 4.6(b) suggest that
strategy B and C combined with the worst-case-optimization approach lead to a relatively
large decrease of dose accumulated in the right OAR. Both strategies B and C use Bayesian
inference in contrast to strategy A. Thus, this finding indicates that Bayesian inference
may be a useful method for robust ART. In contrast to strategy B, strategies A and C
allow for adaptive replanning whenever an adaptation is triggered. The observation that
strategy B and C decrease the dose to the right OAR to similar extent, suggests that an
increased adaptation frequency may not be as effective as Bayesian inference in robust
ART. Here, adaptation costs are lower for strategy B than for C. Thus, the mathematical
methods used in adaptive replanning may have a greater impact on the resulting dose than
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Fig. 5 Comparison of the performance of the decision-support framework using strategies A, B and
C combined with expected-value- and worst-case-optimization and the corresponding non-adaptive
strategies on their ability to provide certain percentage values of the prescription dose in 99% of
the CTV.
increased adaptation frequency. Moreover, the simulations indicate that the worst-case-
optimization approach may be more suitable with the Bayesian inference method. This is
in accordance with the sensitivity analysis, which suggests that the worst-case-optimization
approach is more sensitive to inaccuracies in the a priori hypothesis. The approach to
combine mathematical and user-specified adaptation triggers shows the trend for overall
improvement in target coverage for both robust adaptive strategies, and of protection of
the OAR for the adaptive strategies B and C combined with worst-case-optimization. This
may indicate that such an approach may be useful to have a more objective decision-making
process in ART. Overall, these results should be read as a proof-of-concept which may be
used to further develop methods for robust ART.
V. DISCUSSION AND OUTLOOK
In this paper, a novel framework for online robust ART is introduced and evaluated. The
purpose of this novel approach is to handle interfractional geometric variations following a
distribution different from the a priori hypothesis. This framework is designed to address the
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Fig. 6 Comparison of the performance of the decision-support framework using strategies A, B and
C combined with expected-value- and worst-case-optimization and the corresponding non-adaptive
strategies on their ability to spare dose exposure to the right OAR. We choose to show results for
the right OAR, since it closer to the CTV and therefore at greater risk to receive high dose levels.
issues of adaptation costs and computational tractability. Adaptation costs are addressed
by three robust strategies providing Bayesian inference and/or the option of increased adap-
tation frequency. In addition, mathematical adaptation triggers are used in the proposed
framework. Computational tractability is addressed by the concept of scenario-reduction.
To the best of our knowledge, this is the first approach of its kind to online robust ART.
Therefore, this study emphasizes the mathematical properties of the proposed framework
in order to understand which properties may be relevant for handling interfractional geo-
metric variations. For this purpose, the performance of the novel framework is evaluated in
a one-dimensional phantom geometry for a series of simulated treatments. For the sake of
a fair comparison of all strategies, the same population of simulated treatments is used to
analyze the performances of the robust adaptive strategies within the framework. During
these treatments, the one-dimensional phantom geometry is subjected to rigid whole-body
shifts. In this idealized setting, computational effort is reduced as the accumulated dose
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can be computed and tracked in a straightforward manner. As a consequence of model-
ing interfractional geometric variations as rigid shifts, features in the dose distribution can
be directly associated with changes in the corresponding optimization parameter. Thus,
the relevant parameters and mathematical properties for an effective online robust ART
framework can be identified. Examples for the use of a one-dimensional phantom geometry
to analyze a novel approach from a mathematical perspective can be found in the liter-
ature5,6,10,23. Modeling interfractional geometric vaiations as i.i.d. shifts is reasonable for
random setup errors and organ motion13,34,35,37. If organ deformations were included in this
study, finding the relation between features in the dose profile and the corresponding opti-
mization parameter, may have been compromised. Organ-deformations and an application
to patient data are outside the scope of this study and postponed to a follow-up paper. Oth-
erwise, characteristics of the framework in the resulting dose profiles could be overlooked
or mistaken as features caused by a certain beam set-up or organ shape. In addition, the
quadratic penalty objective function is used to exploit its convexity, smoothness and result-
ing globally optimal solutions. Having globally optimal solutions in a mathematical study
is useful for understanding the underlying mechanism between changing parameters and the
resulting dose-profiles. In general, the proposed framework can be combined with any type
of objective function. However, a convex objective function may be preferable in the first
iteration of studying this novel framework for online robust ART. As a consequence of using
a one-dimensional geometry, i.i.d. rigid shifts and the chosen objective function, the results
of this study should be read as proof-of-concept.
Overall, the following insights are gained from this study. First, the simulations suggest
that the proposed framework may be superior in CTV coverage compared to the correspond-
ing non-adaptive robust approach. Second, combining the worst-case-optimization approach
with Bayesian inference appears to perform best in terms of improving CTV while decreas-
ing dose exposure to the OAR. Third, the simulations indicate that adaptation costs may be
controlled by employing mathematical methods such as Bayesian inference in the replanning
process. Fourth, the concept of scenario reduction has been applied to robust planning and
ART and the results suggest that it may be a useful approach to address computational
tractability. This proof-of-concept study provides valuable insights into robustness, adap-
tation strategies and computational tractability for online robust ART. This is crucial for
further development of the proposed framework toward applying the proposed framework
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to clinical patient data.
VI. CONCLUSION
This novel framework for online robust ART combines the strength of robust planning
with the concept of ART using Bayesian inference and scenario-reduction. The results in this
study indicate that methods such as Bayesian inference may be useful to: (i) individualize
plans to the actual interfractional variations of the individual case and (ii) handle adaptation
costs. In particular, the results of this proof-of-concept study suggest that the combination
of the worst-case-optimization approach with Bayesian inference may lead to the largest im-
provements in CTV coverage and OAR protection among the studied strategies. Moreover,
the results suggest that the concept of scenario-reduction and tree-generation may be useful
for ART and robust planning in general.
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